Angiotech Pharmaceuticals, Inc. announces conference call a... ( Second Quarter 2009 Financial Results...)

Angiotech Pharmaceuticals, Inc. announces conference call and webcast

Date:7/6/2009

Second Quarter 2009 Financial Results

VANCOUVER, July 6 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) will host a conference call discussing its financial results for the second quarter ended June 30, 2009, on Thursday August 6, 2009 at 11:00 AM ET (8:00 AM Pacific).

    Dial-in information for the earnings call on August 6, 2009 is as
    follows:
    North America (toll-free): 866.700.6067
    International: 617.213.8834
    Enter Passcode: 91816046

A live webcast of the earnings call will be available to interested parties through Angiotech's website at www.angiotech.com in the Investor Relations section.

A press release announcing Angiotech's financial results will be issued prior to the call on August 6th at approximately 8:00 AM ET (5:00 AM Pacific).

An archived replay of the call will be available until August 13, 2009.

    Replay information is as follows:
    North America (toll-free): 888.286.8010
    International: 617.801.6888
    Enter Passcode: 23483326

About Angiotech Pharmaceuticals

Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company with over 1,500 dedicated employees. Angiotech discovers, develops and markets innovative treatment solutions for diseases or complications associated with medical device implants, surgical interventions and acute injury. To find out more about Angiotech (NASDAQ: ANPI, TSX: ANP), please visit our website at www.angiotech.com.

SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Post Your Comments:

(Date:11/24/2009)...ent grew by 29,000 jobs in October, and the field...ring the U.S. recession. However, clinics and spec...ems are coming closer to having to actually cut me..., (Vocus) November 24, 200...ctober despite the shedding of jobs in most other ...

(Date:11/24/2009)...EnergyCorp.announcedtodaythatthecompanyandtheOdess...ed$2millionbyWashingtonState,sCommunityEconomicRev...toconstructthestate,sfirstspecialtybiochemicalbior...llsignificantlyspeedthedevelopmentofourbiorefinery...rbleEnergyCEOKellyOgilvie."WearegratefultotheGover...

(Date:11/24/2009)...all/--ArenaPharmaceuticals,Inc.(Nasdaq: ARNA )anno...ePiperJaffray21stAnnualHealthCareConferenceonDecem...e)attheNewYorkPalaceHotelinNewYorkCity.JackLief,Ar...edtoprovideanoverviewofthecompany,includingitsclin...diowebcastofthepresentationwillbeavailableunderthe...

(Date:11/24/2009)...CellTherapeutics,Inc.(CTI)(NasdaqandMTA:CTIC)manag...areConference.TheconferencewillbeheldDecember1-2,2...nTuesday,December1at11:00a.m.EasternTimeinHolmes1(...beavailableat www.celltherapeutics.com ,anditwilla...yHealthCareConference,NewYorkPalaceHotel,Holmes1(4...

Breaking Biology Technology:The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2 The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3 The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4 Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2 Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2

[0] The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close [0] Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board [0] Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference [0] Cell Therapeutics, Inc. (CTI) to Present at 21st Annual Piper Jaffray Health Care Conference

...eguard Mezzanine Debt Facility; Support Profitable...nt , Inc. (Nasdaq: CLRT ), a premier anatomic p...or pathologists, oncologists and the pharmaceutica...the second tranche of a private placement of conve...ers , a multi-stage venture capital firm based in...

...a-FirstCall/ -- China Dasheng,Biotechnology Compan... Board:,CDBT), a leading producer and distributor ...livestock feeds in the PRC, announced unaudited fi...ar 2009, which ended March 31, 2009. , , Highli... -- Total revenue grew approximately 43% to $5....

...ia-FirstCall/ -- Rodobo International,Inc. (OTC Bu...t dairy,companies in China, reported financial res...nded March 31, 2009. , Second quarter financia... quarter ended March 31, 2009 was $6.3 million, an...e was primarily driven by,volume growth, with aver...

Other Biology Technology:Clarient Completes Second Tranche of Private Placement of Convertible Preferred Stock With Oak Investment Partners 2 Clarient Completes Second Tranche of Private Placement of Convertible Preferred Stock With Oak Investment Partners 3 Clarient Completes Second Tranche of Private Placement of Convertible Preferred Stock With Oak Investment Partners 4 Clarient Completes Second Tranche of Private Placement of Convertible Preferred Stock With Oak Investment Partners 5 Clarient Completes Second Tranche of Private Placement of Convertible Preferred Stock With Oak Investment Partners 6 China Dasheng Biotechnology Company Reports Unaudited Third Quarter FY2009 Financial Results 2 China Dasheng Biotechnology Company Reports Unaudited Third Quarter FY2009 Financial Results 3 China Dasheng Biotechnology Company Reports Unaudited Third Quarter FY2009 Financial Results 4 China Dasheng Biotechnology Company Reports Unaudited Third Quarter FY2009 Financial Results 5 China Dasheng Biotechnology Company Reports Unaudited Third Quarter FY2009 Financial Results 6 China Dasheng Biotechnology Company Reports Unaudited Third Quarter FY2009 Financial Results 7 China Dasheng Biotechnology Company Reports Unaudited Third Quarter FY2009 Financial Results 8 Rodobo International, Inc. Reports Q2 and First Half of 2009 2 Rodobo International, Inc. Reports Q2 and First Half of 2009 3 Rodobo International, Inc. Reports Q2 and First Half of 2009 4 Rodobo International, Inc. Reports Q2 and First Half of 2009 5 Rodobo International, Inc. Reports Q2 and First Half of 2009 6 Rodobo International, Inc. Reports Q2 and First Half of 2009 7 Rodobo International, Inc. Reports Q2 and First Half of 2009 8

Clarient Completes Second Tranche of Private Placement of Convertible Preferred Stock With Oak Investment Partners China Dasheng Biotechnology Company Reports Unaudited Third Quarter FY2009 Financial Results Rodobo International, Inc. Reports Q2 and First Half of 2009

(Date:11/23/2009)...g of recent discoveries about the multiple health ... multi-purpose nutrient, increased awareness of th...spurred research and even led to an appreciation o...ng from the health of your immune system to preven...fluenza, vitamin D is now seen as one of the most ...

(Date:11/23/2009)...sify the gender of six-week-old turkey poults coul...hortly after birth, according to Dr. Gerald Steine...many and his team. Their use of infrared spectrosc...hat it is a fast and accurate method with the pote...ify and select female eggs for breeding. The pilot...

(Date:11/23/2009)...le in German . , A bit of imagination on th... thing. It could help to add data from areas where...must do so constructively. In order to infer missi...han just imagination, physicists at the Max Planck...ry of spatial perception called information field ...

[0] Multiple health concerns surface as winter, vitamin D deficiences arrive [0] Rescuing male turkey chicks [0] Visual assistance for cosmic blind spots

...ate University have made a major discovery on the ...anisms of one of life,s most elemental functions: ... for how a normal cell forms a tumor and how a vir...13 edition of the scientific journal Molecular Cel...ds exquisite nanotechnology in living systems and ...

...d be saved if $5.1 billion in new resources for pr...ed each year, according to researchers from the Jo...other institutions. Approximately 90 percent of al...rld. In those countries, the average cost per chil...e recent publication of the potential impact of pr...

...rthern and southern hemispheres are linked by a ph...ither side of the planet. A research team from the... University has shown for the first time that ocea...he past, adapted to sudden changes in the north. T... more accurate forecasts to be made on how the oce...

Other Biology News:High fidelity keeps human DNA assembly line humming 2 $5.1 billion would save 6 million children 2 $5.1 billion would save 6 million children 3 Climatologists discover deep-sea secret 2

High fidelity keeps human DNA assembly line humming $5.1 billion would save 6 million children Climatologists discover deep-sea secret

Rabbit Anti-Smac / DIABLO, C Terminus Antibody, Unconjugated from BACHEM

Mouse Anti-Integrin alpha M Monoclonal Antibody, Unconjugated, Clone ICRF 44 from Novus Biologicals

Finnpipette Focus Single Channel Long Tip Cone 30-300l from Thermo Scientific

...ion system for small volumes of precious solution ...neral liquid-handling research applications. Del...s. Switch between four or eight solutions in milli...nation with BackStop back-flow prevention. Special...

Biology Products:

Rabbit Anti-Smac / DIABLO, C Terminus Antibody, Unconjugated from BACHEM Mouse Anti-Integrin alpha M Monoclonal Antibody, Unconjugated, Clone ICRF 44 from Novus Biologicals Finnpipette Focus Single Channel Long Tip Cone 30-300l from Thermo Scientific SmartSquirt8 Micro-Perfusion System from AutoMate Scientific, Inc

Angiotech Pharmaceuticals, Inc. announces conference call a...( Second Quarter 2009 Financial Results...)